BackCH Biotech R&D , Ltd. Overview

CH Biotech R&D , Ltd. Net Tangible Assets

Latest net tangible assets for 6534.TW: $2.6B.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$2.63B
↓ 1.65% YoYΔ $-44.12M vs prior year quarter

Peer trimmed avg / median

Loading

CH Biotech R&D , Ltd. Net Tangible Assets History

Loading

CH Biotech R&D , Ltd. vs. peers: Net Tangible Assets Comparison

Loading

CH Biotech R&D , Ltd. Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

CH Biotech R&D , Ltd. (6534.TW) FAQ

As of the most recent data (June 2026), 6534.TW shows a net tangible assets of $2.6B. That compares with $2.7B in the prior-year period — down 1.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6534.TW's net tangible assets is now $2.6B (was $2.7B) — a 1.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether CH Biotech R&D , Ltd. is outperforming or lagging.

Tracking 6534.TW's net tangible assets over time shows whether CH Biotech R&D , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $2.6B That compares with $2.7B in the prior-year period — down 1.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has CH Biotech R&D , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $2.6B) with ownership activity and broader fundamentals.